Cargando…

The RAP study, report 3: Discoloration of the macular region in patients with macular neovascularization type 3

BACKGROUND/AIMS: To explore whether the existence and pattern of distribution of macular haemorrhage or exudate can be valuable diagnostic markers for macular neovascularization type 3 (MNV3) in patients with neovascular age‐related macular degeneration. METHODS: Eighty‐three eyes of 83 consecutive...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haj Najeeb, Bilal, Deak, Gabor G., Schmidt‐Erfurth, Ursula, Gerendas, Bianca S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292611/ https://www.ncbi.nlm.nih.gov/pubmed/33821577 http://dx.doi.org/10.1111/aos.14866

Ejemplares similares

The RAP study, report 4: morphological and topographical characteristics of multifocal macular neovascularization type 3
por: Haj Najeeb, Bilal, et al.
Publicado: (2021)

THE RAP STUDY, REPORT 5: REDISCOVERING MACULAR NEOVASCULARIZATION TYPE 3: Multimodal Imaging of Fellow Eyes over 24 months
por: Haj Najeeb, Bilal, et al.
Publicado: (2022)

Segmentation of macular neovascularization and leakage in fluorescein angiography images in neovascular age-related macular degeneration using deep learning
por: Holomcik, David, et al.
Publicado: (2022)

Do patients with unilateral macular neovascularization type 3 need AREDS supplements to slow the progression to advanced age-related macular degeneration?
por: Haj Najeeb, Bilal, et al.
Publicado: (2022)

Automated Fovea Detection in Spectral Domain Optical Coherence Tomography Scans of Exudative Macular Disease
por: Wu, Jing, et al.
Publicado: (2016)

Quantitative assessment of retinal fluid in neovascular age-related macular degeneration under anti-VEGF therapy
por: Reiter, Gregor S., et al.
Publicado: (2022)

Automated Quantification of Photoreceptor alteration in macular disease using Optical Coherence Tomography and Deep Learning
por: Orlando, José Ignacio, et al.
Publicado: (2020)

Morphologic and Microvascular Differences Between Macular Neovascularization With and Without Subretinal Fibrosis
por: Roberts, Philipp Ken, et al.
Publicado: (2021)

Progression of Retinal Pigment Epithelial Atrophy in Antiangiogenic Therapy of Neovascular Age-Related Macular Degeneration
por: Schütze, Christopher, et al.
Publicado: (2015)

Baseline predictors for subretinal fibrosis in neovascular age-related macular degeneration
por: Roberts, Philipp K., et al.
Publicado: (2022)

Short‐time effect of intravitreal injections on retinal vascular oxygenation and vessel diameter in patients with diabetic macular oedema or neovascular age‐related macular degeneration
por: Mitsch, Christoph, et al.
Publicado: (2019)

Type-3 macular neovascularization in a case of long-standing macular telangiectasia type-2
por: Chandran, Kiran, et al.
Publicado: (2023)

Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA)
por: Schmidt-Erfurth, Ursula, et al.
Publicado: (2014)

Type 1 Idiopathic Macular Telangiectasia Associated with Type 3 Neovascularization
por: Tilleul, Julien, et al.
Publicado: (2014)

Predicting treat-and-extend outcomes and treatment intervals in neovascular age-related macular degeneration from retinal optical coherence tomography using artificial intelligence
por: Bogunović, Hrvoje, et al.
Publicado: (2022)

Evaluation of optical coherence tomography findings in age-related macular degeneration: a reproducibility study of two independent reading centres
por: Ritter, Markus, et al.
Publicado: (2010)

Profiling neovascular age‐related macular degeneration choroidal neovascularization lesion response to anti‐vascular endothelial growth factor therapy using SSOCTA
por: Told, Reinhard, et al.
Publicado: (2020)

Type 3 macular neovascularization in a patient with pentosan polysulfate maculopathy
por: Bousquet, Elodie, et al.
Publicado: (2022)

Correlation of vascular and fluid‐related parameters in neovascular age‐related macular degeneration using deep learning
por: Schranz, Markus, et al.
Publicado: (2022)

Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration
por: Ahmed, Daniel, et al.
Publicado: (2020)

Impact of macular fluid features on outcomes of anti-vascular endothelial growth factor treatment for type 3 macular neovascularization
por: Yoon, Wontae, et al.
Publicado: (2021)

Histology of Type 3 Macular Neovascularization and Microvascular Anomalies in Treated Age-Related Macular Degeneration: A Case Study
por: Berlin, Andreas, et al.
Publicado: (2023)

Macular neovascularization lesion type and vision outcomes in neovascular age-related macular degeneration: post hoc analysis of HARBOR
por: Freund, K. Bailey, et al.
Publicado: (2022)

Clinical Pathological Features and Current Animal Models of Type 3 Macular Neovascularization
por: Qiang, Wei, et al.
Publicado: (2021)

Blood flow pattern in eye before development of type 3 macular neovascularization
por: Yamaguchi, Saya, et al.
Publicado: (2023)

Correction to: Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration
por: Ahmed, Daniel, et al.
Publicado: (2020)

Macular neovascularization in eyes with pachydrusen
por: Teo, Kelvin Yi Chong, et al.
Publicado: (2021)

Correlation between Macular Neovascularization (MNV) Type and Druse Type in Neovascular Age-Related Macular Degeneration (AMD) Based on the CONAN Classification
por: Muth, Daniel Rudolf, et al.
Publicado: (2022)

Microvascular abnormalities and long-term efficacy after stereotactic radiotherapy under continued intravitreal anti-VEGF treatment for neovascular AMD
por: Hatz, Katja, et al.
Publicado: (2022)

Early OCTA Changes of Type 3 Macular Neovascularization Following Brolucizumab Intravitreal Injections
por: Gigon, Anthony, et al.
Publicado: (2022)

Retinal oxygen saturation, vessel diameter and flicker response in eyes with specific subtypes of neovascular age-related macular degeneration during aflibercept treatment
por: Sacu, Stefan, et al.
Publicado: (2022)

Histology of neovascular myopic macular degeneration
por: Jonas, Shefali B., et al.
Publicado: (2021)

Brolucizumab in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Ophthalmology and Diabetology Treatment Aspects
por: Garweg, Justus G., et al.
Publicado: (2023)

Evolution of macular atrophy in eyes with neovascular age-related macular degeneration compared to fellow non-neovascular eyes
por: Blazaki, Styliani, et al.
Publicado: (2023)

Comparison of Stimulus Types for Retinotopic Cortical Mapping of Macular Disease
por: Pawloff, Maximilian, et al.
Publicado: (2023)

Choroidal Modifications Preceding the Onset of Macular Neovascularization in Age-Related Macular Degeneration
por: Arrigo, Alessandro, et al.
Publicado: (2021)

Faricimab for the Treatment of Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration
por: Ferro Desideri, Lorenzo, et al.
Publicado: (2023)

Choroidal and Retinal Imaging Biomarkers in Different Types of Macular Neovascularization
por: Toto, Lisa, et al.
Publicado: (2023)

Functional versus functional and anatomical criteria-guided ranibizumab treatment in patients with neovascular age-related macular degeneration – results from the randomized, phase IIIb OCTAVE study
por: Staurenghi, Giovanni, et al.
Publicado: (2020)

Swept Source Optical Coherence Tomography Angiography: Characteristic Findings in Type 3 Macular Neovascularization
por: Matri, Khaled El, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_u35fm64eq6tu0c6hvm5jlat94l